Page 5 - Titanium Technologies News Today

More news about other top positions as well.

Shares of The Chemours Company (NYSE:CC – Get Free Report) have been assigned an average recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has assigned a buy […]

UBS Group reaffirmed their neutral rating on shares of Chemours (NYSE:CC – Free Report) in a report published on Tuesday, Marketbeat Ratings reports. UBS Group currently has a $21.00 price target on the specialty chemicals company’s stock, down from their prior price target of $37.00. A number of other equities research analysts have also recently […]

California State Teachers Retirement System decreased its position in shares of The Chemours Company (NYSE:CC – Free Report) by 8.6% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 166,614 shares of the specialty chemicals company’s stock after selling 15,728 shares during the period. […]

The Board of Directors of The Chemours Company has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer . Ms. Dignam joined...

Chemours Company reports prelim results, management changes, and delay in 10-K form. Net sales down, net loss expected.

Wilmington-based chemical giant The Chemours Co., a spinoff of DuPont chemical empire, is in apparent tumult at the uppermost levels of management.

Sherbrooke Park Advisers LLC bought a new position in The Chemours Company (NYSE:CC – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 37,202 shares of the specialty chemicals company’s stock, valued at approximately $1,044,000. A number of […]

Sherbrooke Park Advisers LLC acquired a new position in shares of The Chemours Company (NYSE:CC – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 37,202 shares of the specialty chemicals company’s stock, valued at approximately […]

Chemours Celebrates Black History Month and HBCUs Role in Helping Create ...